Breaking the Steroid Cycle: New Maintenance Strategies for IgG4-RD Patients in 2025
For decades, the "steroid taper" has been a source of anxiety for IgG4-RD patients. While glucocorticoids are incredibly effective at bringing down immediate inflammation, the risk of a flare-up once the dose is lowered remains high—between 30% and 50% in many cohorts. This "yo-yo" effect of inflammation and remission can lead to cumulative organ damage and a poor quality of life. In...
0 Commenti 0 condivisioni 78 Views 0 Anteprima